2026 Calls for a Global Health System Connectivity Compact: EHR/EMR, Interoperability, and Cybersecurity Vendors Urged to Protect Continuity of Care During Conflict and Recovery 
Central IRB Approved for ABV-1505 Phase II Part II in Taiwan Sites
ABVC BioPharma Receives Taiwan Regulatory Approval for ABV-1505 ADHD Phase II Part 2 Clinical Study Completion of the Study Expected...
Sarepta Therapeutics to Announce Third Quarter 2021 Financial Results and Recent Corporate Developments on November 3, 2021
CAMBRIDGE, Mass., Oct. 27, 2021 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare...
Truepill Raises $142 Million Series D to Continue Transforming Consumer Healthcare
Funding round brings total investment to $256 million and valuation to $1.6 billionSAN MATEO, Calif., Oct. 27, 2021 (GLOBE NEWSWIRE)...
Exagen Inc. Expands Coverage with Inland Empire Health Plan, Partnering to Provide More Accurate Diagnostic Testing with AVISE® CTD and AVISE Lupus
SAN DIEGO, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today that...
Silo Pharma Enters into Sponsored Research Agreement with Columbia University to Develop Psychedelic Therapeutics for Alzheimer’s Disease
Agreement Provides for Option to License Alzheimer’s TherapeuticEnglewood Cliffs, NJ, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (OTCQB:...
TRACON to Report Third Quarter 2021 Financial Results and Company Highlights on November 3, 2021
SAN DIEGO, Oct. 27, 2021 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development...
Monopar Announces First Patient Dosed in Phase 1b Trial Evaluating Camsirubicin for the Treatment of Advanced Soft Tissue Sarcoma
WILMETTE, Ill., Oct. 27, 2021 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing...
Histogen to Report Third Quarter 2021 Financial Results on November 10, 2021
SAN DIEGO, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing potential...
Science 37® and CMIC Announce Partnership to Advance Decentralized Clinical Trials in Japan/APAC and Speed Drug Development
LOS ANGELES and TOKYO, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Science 37, the Operating System for today’s more agile clinical...
Aveanna Announces Third Quarter 2021 Earnings Release Date and Conference Call
ATLANTA, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH) today announced that the company will release...
Galectin Pharmaceuticals to Present Six Scientific Abstracts at The Liver Meeting™ 2021, Hosted by the AASLD
New data regarding the mechanism of action of belapectin to inhibit galectin-3Unique pharmacokinetic profile of belapectin in patients with hepatic...
Access Vascular Inc. and Eloquest Healthcare Partner to Improve Vascular Access Outcomes
The partnership combines Eloquest’s existing clinically oriented product offering and commercial resources with AVI’s transformational device technologyBEDFORD, Mass., Oct. 27,...
InnerScope Hearing Technologies (OTC: INND) Acquiring Hearing Assist – Walmart’s Largest Hearing Aid Supplier
Highlights of Hearing Assist II LLC Over 500,000 Hearing Aids SoldNearly 400,000 customers Sold in 757 Walmart Stores & on Walmart.com Generated...
Intercept to Announce Third Quarter 2021 Financial Results on November 3, 2021
NEW YORK, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization...
Medicenna Announces FDA Clearance of IND to Expand the Phase 1/2 ABILITY Study of MDNA11 to the United States
-- ABILITY Study is currently ongoing at clinical trial sites in Australia -- Preliminary update on safety, PK/PD, and biomarker...
Solaris Pharma Receives FDA Approval for Generic Metrogel-Vaginal®
Solaris Pharma Receives FDA Approval for Generic Metrogel-Vaginal® Solaris Pharma Receives FDA Approval for Generic Metrogel-Vaginal® -- Current annual market...
Science 37® and 3H Medi Solution Collaborate to Enable Decentralized Clinical Trials in Japan and Accelerate Patient Enrollment
LOS ANGELES and TOKYO, Oct. 27, 2021 (GLOBE NEWSWIRE) -- Science 37, the Operating System for today’s more agile clinical...
Pasithea Therapeutics Announces Successful Treatment of First Patients in the UK with Ketamine Infusion Therapy
– Pasithea Clinics commences IV ketamine infusion therapy in Knightsbridge, London, for the treatment of mental health disorders –MIAMI BEACH, Fla., Oct....
Context Therapeutics® and Wisconsin Oncology Network Announce First Patient Dosed in Phase 2 Trial of ONA-XR in Metastatic Breast Cancer
Trial Will Evaluate Progesterone Receptor ONA-XR in Combination with Estrogen Receptor Antagonist to Determine Potential of Complete Hormone Blockade on...
Mydecine Reports Successful Synthesis of Novel Tryptamine Improving the Pharmaceutical Properties of Psilocin
Further strengthens the Company’s drug development pipeline of tryptamines by introducing novel psilocin analogues containing enhancements in safety and efficacy...